Evolus, Inc. - Common Stock (EOLS)

CUSIP: 30052C107

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 7 signals
Share change
-6,708,624
Put/Call ratio
12%
SEC-reported price per share
$6.65
Number of holders
169
Value change
-$41,089,898
Number of buys
90
Open additional details 1 more signal available
Number of sells
79
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
64,879,792

Security key

30052C107

Report period

Q4 2025

Institutions

169

Top holders

10

Ownership snapshot

Top reported holders of EOLS - Evolus, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Timothy P. Lynch
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G 13F 3/4/5 Lead comparable stake: 9.9% 13D/G row: Timothy P. Lynch Showing 1-6 of 15 holder rows.

Quick read

Timothy P. Lynch leads the comparable SEC ownership view at 9.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Timothy P. Lynch's linked filing trail.
Comparable ownership Top 5
Timothy P. Lynch 9.9%
Nantahala Capital Management, LLC 8.8%
BlackRock, Inc. 6.9%
PERCEPTIVE ADVISORS LLC 3.8%
Medytox Inc. 3.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Timothy P. Lynch
13D/G
9.9%
$36,305,352
6,425,726 shares
+$7,299,518 31 Dec 2025
Nantahala Capital Management, LLC
13F 13D/G
Company
8.8%
from 13D/G
$35,162,902
5,726,857 shares
30 Sep 2025
BlackRock, Inc.
13D/G 13F
Company
6.9%
$50,851,038
4,364,896 shares
$0 31 Dec 2024
PERCEPTIVE ADVISORS LLC
13D/G
3.8%
$23,461,512
2,474,843 shares
-$15,682,755 30 Jun 2025
Medytox Inc.
3/4/5 13D/G
Former 10% Owner
3.4%
from 13D/G
$25,359,945
3,381,326 shares
16 Oct 2023
TANG CAPITAL MANAGEMENT LLC
13F 13D/G
Company
1.9%
from 13D/G
$33,698,156
5,488,299 shares
30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
169
Shares
49,221,799
Rows available
169
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
158
Q4 2025 holders
169
Holder diff
11
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .